1. Home
  2. EDRY vs ESLA Comparison

EDRY vs ESLA Comparison

Compare EDRY & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDRY
  • ESLA
  • Stock Information
  • Founded
  • EDRY 2018
  • ESLA 2021
  • Country
  • EDRY Greece
  • ESLA United States
  • Employees
  • EDRY N/A
  • ESLA N/A
  • Industry
  • EDRY Marine Transportation
  • ESLA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EDRY Consumer Discretionary
  • ESLA Health Care
  • Exchange
  • EDRY Nasdaq
  • ESLA Nasdaq
  • Market Cap
  • EDRY 38.5M
  • ESLA 41.6M
  • IPO Year
  • EDRY N/A
  • ESLA N/A
  • Fundamental
  • Price
  • EDRY $10.75
  • ESLA $1.12
  • Analyst Decision
  • EDRY
  • ESLA
  • Analyst Count
  • EDRY 0
  • ESLA 0
  • Target Price
  • EDRY N/A
  • ESLA N/A
  • AVG Volume (30 Days)
  • EDRY 9.3K
  • ESLA 59.0K
  • Earning Date
  • EDRY 11-19-2024
  • ESLA 02-12-2025
  • Dividend Yield
  • EDRY N/A
  • ESLA N/A
  • EPS Growth
  • EDRY N/A
  • ESLA N/A
  • EPS
  • EDRY N/A
  • ESLA N/A
  • Revenue
  • EDRY $65,085,280.00
  • ESLA N/A
  • Revenue This Year
  • EDRY $34.61
  • ESLA N/A
  • Revenue Next Year
  • EDRY $15.93
  • ESLA N/A
  • P/E Ratio
  • EDRY N/A
  • ESLA N/A
  • Revenue Growth
  • EDRY 39.04
  • ESLA N/A
  • 52 Week Low
  • EDRY $11.09
  • ESLA $0.63
  • 52 Week High
  • EDRY $24.84
  • ESLA $3.23
  • Technical
  • Relative Strength Index (RSI)
  • EDRY 16.70
  • ESLA 56.94
  • Support Level
  • EDRY $13.00
  • ESLA $1.03
  • Resistance Level
  • EDRY $13.22
  • ESLA $1.39
  • Average True Range (ATR)
  • EDRY 0.46
  • ESLA 0.19
  • MACD
  • EDRY -0.11
  • ESLA -0.00
  • Stochastic Oscillator
  • EDRY 18.69
  • ESLA 47.42

About EDRY EuroDry Ltd.

EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulks such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers.

About ESLA Estrella Immunopharma Inc.

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.

Share on Social Networks: